Doxorubicin Impurity 27 | CAS 105612-58-6 - Request Quote
Doxorubicin Impurity 27
| SZ CAT No: | SZ-D051035 |
| CAS No | 105612-58-6 |
| Mol.F. | C21H14O7 |
| Mol.Wt. | 378.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Doxorubicin Impurity 27 is chemically 6,11-Dihydroxy-8-(2-hydroxyacetyl)-1-methoxytetracene-5,12-dione. Doxorubicin Impurity 27 is supplied with detailed characterization data compliant with regulatory guideline. Doxorubicin Impurity 27 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Doxorubicin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 105612-58-6
Purchase 105612-58-6
Order 105612-58-6
Enquire 105612-58-6
price of 105612-58-6
105612-58-6 Supplier
105612-58-6 Manufacturer
105612-58-6 Exporter
buy high quality Doxorubicin Impurity 27
Purchase Doxorubicin Impurity 27
Doxorubicin Impurity 27 suppliers
Doxorubicin Impurity 27 manufacturers
Doxorubicin Impurity 27 price
Order Doxorubicin Impurity 27
Enquire Doxorubicin Impurity 27
Doxorubicin Impurity 27 cost
Doxorubicin Impurity 27 Supplier
Doxorubicin Impurity 27 Distributor
Doxorubicin Impurity 27 for Method Validation
Doxorubicin Reference Standard
Doxorubicin Impurity 27 for ANDA Filing
Doxorubicin Impurity 27 for Forced Degradation Studies
Doxorubicin Impurity 27 Identification Standards
Doxorubicin Impurity 27 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


